Evidence map›Paper›PMID 28719151›Full record

ArticleEarly intervention in psychiatry2018

Staged Treatment in Early Psychosis: A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients.

Barnaby Nelson, G Paul Amminger, Hok Pan Yuen, Nicky Wallis, Melissa J Kerr, Lisa Dixon, Cameron Carter, Rachel Loewy, Tara A Niendam, Martha Shumway and 3 more

Open access · bronzeAbstract readClinical Trial Protocol
In one paragraph

Article in Early intervention in psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 76 citations in OpenAlex.

  1. Psychological interventions for psychosis in adolescents.The Cochrane database of systematic reviews · 2020
    Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Cognitive Behavior Therapy at the Crossroads.International journal of cognitive therapy · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Barnaby NelsonOrygen, The National Centre of Excellence in Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
G Paul AmmingerOrygen, The National Centre of Excellence in Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
Hok Pan YuenOrygen, The National Centre of Excellence in Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
Nicky WallisOrygen, The National Centre of Excellence in Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
Melissa J KerrOrygen, The National Centre of Excellence in Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
Lisa DixonDepartment of Psychiatry, Columbia University, New York, New York.
Cameron CarterDepartment of Psychiatry and Behavioral Sciences, University of California Davis, Davis, California.
Rachel LoewyDepartment of Psychiatry, University of California San Francisco, San Francisco, California.
Tara A NiendamDepartment of Psychiatry and Behavioral Sciences, University of California Davis, Davis, California.
Martha ShumwayDepartment of Psychiatry, University of California San Francisco, San Francisco, California.
Sarah MorrisNational Institute of Mental Health, Bethesda, MD, USA.
Julie BlasioliOrygen, The National Centre of Excellence in Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
Patrick D McGorryOrygen, The National Centre of Excellence in Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
Orygen Youth Health · AUUniversity of Melbourne · AUUniversity of California, Davis · USColumbia University · USNational Institute of Mental Health · USUniversity of California, San Francisco · USUniversity of San Francisco · US

Funding

Building the Evidence Base for Adaptive Treatment Sequences in Clinical High RiskU01MH105258 · NIMH · ORYGEN YOUTH HEALTH RESEARCH CENTRE · PI MCGORRY, PATRICK · 2015 to 2019
$6.0M
NIMH NIH HHS U01 MH105258
6 · The paper itself

Abstract

aimPrevious research indicates that preventive intervention is likely to benefit patients "at risk" of psychosis, in terms of functional improvement, symptom reduction and delay or prevention of onset of threshold psychotic disorder. The primary aim of the current study is to test outcomes of ultra high risk (UHR) patients, primarily functional outcome, in response to a sequential intervention strategy consisting of support and problem solving (SPS), cognitive-behavioural case management and antidepressant medication. A secondary aim is to test biological and psychological variables that moderate and mediate response to this sequential treatment strategy.

methodsThis is a sequential multiple assignment randomised trial (SMART) consisting of three steps: Step 1: SPS (1.5 months); Step 2: SPS vs Cognitive Behavioural Case Management (4.5 months); Step 3: Cognitive Behavioural Case Management + Antidepressant Medication vs Cognitive Behavioural Case Management + Placebo (6 months). The intervention is of 12 months duration in total and participants will be followed up at 18 months and 24 months post baseline.

conclusionThis paper reports on the rationale and protocol of the Staged Treatment in Early Psychosis (STEP) study. With a large sample of 500 UHR participants this study will investigate the most effective type and sequence of treatments for improving functioning and reducing the risk of developing psychotic disorder in this clinical population.

Indexed as

Cognitive Behavioral TherapyEarly Medical InterventionPsychotic DisordersVulnerable PopulationsAdolescentAdultAntidepressive AgentsChildCombined Modality TherapyHumansRandomized Controlled Trials as TopicYoung AdultAntidepressive Agentsantidepressant medicationclinical trialprodromepsychosisultra high risk

Identifiers

PMID28719151
PMCPMC6054879
OpenAlexW2738667277

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.